Drugs Made In America Acquisition DMII
NASDAQ DMII
$10.19 +0.00 (+0.00%)
As of: Oct 5, 2026 · 3:45 PM EDT

Drugs Made In America Acquisition (DMII) Net Cash Flow (2025)

Updated

Drugs Made In America Acquisition (DMII) posted Net Cash Flow of -$314,864 for Q4 2025.

Analysis

Drugs Made In America Acquisition (DMII) Net Cash Flow (2025) Analysis & Trends

For FY2025, Drugs Made In America Acquisition's Net Cash Flow came in at -$16,812.

  • In prior years, Drugs Made In America Acquisition's Net Cash Flow was $17,035 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF (Qtr)
1 BlackRock 164.13 Bn 110.49 Bn - 650.00 Mn
2 Spdr Gold Trust 133.82 Bn -424.18 Bn - -
3 Blackstone 84.08 Bn 79.01 Bn - 64.65 Mn
4 Brookfield 82.97 Bn -82.41 Bn 4.47 Bn -
5 Kkr 81.05 Bn 47.53 Bn - 1.70 Bn
6 Brookfield Asset Management 71.64 Bn 67.88 Bn - 410.00 Mn
7 Apollo Global Management 65.67 Bn 3.35 Bn 10.56 Bn 4.67 Bn
8 Wheaton Precious Metals 61.89 Bn 57.32 Bn 687.86 Mn 2.44 Bn
9 Franco Nevada 46.13 Bn 43.49 Bn 451.00 Mn 299.90 Mn
10 Drugs Made In America Acquisition 649.10 Mn 649.10 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -314,864.00
Sep 30, 2025 -690,726.00
API Access

Drugs Made In America Acquisition Net Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-cash-flow&ticker=DMII&period=max&api_key=YOUR_API_KEY